Page last updated: 2024-09-04

imidazole-4-carboxamide and Diabetes Mellitus, Type 2

imidazole-4-carboxamide has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acevedo-Duncan, M; Braun, U; Farese, RV; Fields, AP; Kahn, CR; Leitges, M; Mastorides, S; Nimal, S; Sajan, MP	1

Other Studies

1 other study(ies) available for imidazole-4-carboxamide and Diabetes Mellitus, Type 2

Article	Year
Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:4 Topics: Aminoimidazole Carboxamide; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Female; Insulin; Isoenzymes; Liver; Male; Metabolic Syndrome; Mice; Mice, Knockout; Obesity; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Triglycerides	2012

Article

Year

Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.

Metabolism: clinical and experimental, 2012, Volume: 61, Issue:4

Topics: Aminoimidazole Carboxamide; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Female; Insulin; Isoenzymes; Liver; Male; Metabolic Syndrome; Mice; Mice, Knockout; Obesity; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Triglycerides

2012